Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Gori S, De Rose F, Ferro A, Fabi A, Angiolini C, Azzarello G, Cancian M, Cinquini M, Arecco L, Aristei C, Bernardi D, Biganzoli L, Cariello A, Cortesi L, Cretella E, Criscitiello C, De Giorgi U, Carmen De Santis M, Deledda G, Dessena M, Donati S, Dri A, Ferretti G, Foglietta J, Franceschini D, Franco P, Schirone A, Generali D, Gianni L, Giordani S, Grandi G, Cristina Leonardi M, Magno S, Malorni L, Mantoan C, Martorana F, Meattini I, Meduri B, Merlini L, Miglietta F, Modena A, Nicolis F, Palumbo I, Panizza P, Angela Rovera F, Salvini P, Santoro A, Taffurelli M, Toss A, Tralongo P, Turazza M, Valerio M, Verzè M, Vici P, Zamagni C, Curigliano G, Pappagallo G, Zambelli A; Italian Association of Multidisciplinary Oncology Groups (AIGOM). Gori S, et al. Among authors: verze m. Cancer Treat Rev. 2024 Dec;131:102832. doi: 10.1016/j.ctrv.2024.102832. Epub 2024 Oct 5. Cancer Treat Rev. 2024. PMID: 39437511 Free article. Review.
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Leonetti A, Cervati V, Minari R, Scarlattei M, Verzè M, Peroni M, Pluchino M, Bonatti F, Perrone F, Mazzaschi G, Cosenza A, Gnetti L, Bordi P, Ruffini L, Tiseo M. Leonetti A, et al. Among authors: verze m. Clin Lung Cancer. 2024 Aug 6:S1525-7304(24)00154-2. doi: 10.1016/j.cllc.2024.07.016. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39198088
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors.
Mazzaschi G, Perrone F, Maglietta G, Favari E, Verzè M, Pluchino M, Minari R, Pecci F, Gnetti L, Campanini N, Silini EM, De Filippo M, Maffezzoli M, Giudice GC, Testi I, Tiseo M, Quaini F, Buti S. Mazzaschi G, et al. Among authors: verze m. J Immunother. 2024 Nov-Dec 01;47(9):388-394. doi: 10.1097/CJI.0000000000000534. Epub 2024 Jul 11. J Immunother. 2024. PMID: 38989743 Free PMC article.
The emotional states and associated behavioral responses (flexible-adaptive behaviors vs. inflexible-maladaptive behaviors) of cancer patients during the SARS-CoV-2 outbreak: A multi-center cross-sectional study in Italy.
Deledda G, Poli S, Giansante M, Geccherle E, Fantoni G, Romaniello I, Gabriella F, Verzè M, Nicolis F, Gori S. Deledda G, et al. Among authors: verze m. Cancer Med. 2024 Jul;13(13):e7442. doi: 10.1002/cam4.7442. Cancer Med. 2024. PMID: 38949180 Free PMC article.
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers.
Caldrer S, Accordini S, Mazzi C, Tiberti N, Deiana M, Matucci A, Rizzi E, Tais S, Filippo F, Verzè M, Cattaneo P, Chiecchi GP, Castilletti C, Delledonne M, Gobbi F, Piubelli C. Caldrer S, et al. Among authors: verze m. Vaccines (Basel). 2024 Feb 23;12(3):230. doi: 10.3390/vaccines12030230. Vaccines (Basel). 2024. PMID: 38543865 Free PMC article.
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.
La Monica S, Vacondio F, Eltayeb K, Lodola A, Volta F, Viglioli M, Ferlenghi F, Galvani F, Galetti M, Bonelli M, Fumarola C, Cavazzoni A, Flammini L, Verzè M, Minari R, Petronini PG, Tiseo M, Mor M, Alfieri R. La Monica S, et al. Among authors: verze m. Sci Rep. 2024 Mar 18;14(1):6491. doi: 10.1038/s41598-024-57028-8. Sci Rep. 2024. PMID: 38499619 Free PMC article.
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC).
Cavazzoni A, Digiacomo G, Volta F, Alfieri R, Giovannetti E, Gnetti L, Bellini L, Galetti M, Fumarola C, Xu G, Bonelli M, La Monica S, Verzè M, Leonetti A, Eltayeb K, D'Agnelli S, Moron Dalla Tor L, Minari R, Petronini PG, Tiseo M. Cavazzoni A, et al. Among authors: verze m. Lung Cancer. 2024 Jan;187:107438. doi: 10.1016/j.lungcan.2023.107438. Epub 2023 Dec 12. Lung Cancer. 2024. PMID: 38100954 Free article.
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies.
Leonetti A, Verzè M, Minari R, Perrone F, Gnetti L, Bordi P, Pluchino M, Nizzoli R, Azzoni C, Bottarelli L, Lagrasta CAM, Mazzaschi G, Buti S, Gasparro D, Cosenza A, Ferri L, Majori M, De Filippo M, Ampollini L, La Monica S, Alfieri R, Silini EM, Tiseo M. Leonetti A, et al. Among authors: verze m. Br J Cancer. 2024 Jan;130(1):135-142. doi: 10.1038/s41416-023-02475-9. Epub 2023 Nov 8. Br J Cancer. 2024. PMID: 37938348 Free PMC article.
29 results